New criticism of Nymox after latest news releases from the company

Nymox Pharma {NASDAQ: NYMX} is the the subject of new criticism following the recent article attacking the company.

Bizarrely the share price has doubled since the last revelation, although it has fallen back after the second critical article.



Nymox Pharma very volatile after criticism and recent news releases.


The share price of Nymox Pharma {NASDAQ: NYMX} halved after a  recent article was published criticising the company and making allegation of impropriety.


The company has failed to respond tot he criticism, but instead ignored it and simply issued new releases claiming success for their recent trials.


Now another critical article has appeared,and once again the share price fell dramatically, but once again the company has issued a positive nes release and the share price is once again climbing.


To read the full article please CLICK HERE


To read the full news release on PDF please click HERE